Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/07/2002US20020165156 Tumor necrosis factor family and its blocking agent
11/07/2002US20020165154 Lipoprotein-regulating medicaments
11/07/2002US20020165149 Mutated class II major histocompatibility proteins
11/07/2002US20020165145 Encode Rho GEF protein members
11/07/2002US20020165142 DAZ genes
11/07/2002US20020165139 Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as Bacillus anthrasis
11/07/2002US20020165135 Compositions and methods related to canine IgG and canine IL-13 receptors
11/07/2002US20020165131 Histidine-rich glycoprotein
11/07/2002US20020165117 Use of purinergic receptor modulators and related reagents
11/07/2002US20020165114 Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same
11/07/2002US20020164804 Method for more efficient electroporation
11/07/2002US20020164803 Nucleotide sequences for use as transformation tools in genetic engineering
11/07/2002US20020164802 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
11/07/2002US20020164801 Human and mammalian DNA replication origin consensus sequences
11/07/2002US20020164800 Retroviral vector
11/07/2002US20020164799 Expression vector coding proteins for use in the treatment of cancer
11/07/2002US20020164798 Process for inducing direct somatic embryogenesis and secondary embryogenesis in monocotyledonous plant cells, and rapidly regenerating fertile plants
11/07/2002US20020164793 Generating skin cells; obtain skin cells, keratinocytes and nutrient broths, culture cell, recover cells
11/07/2002US20020164792 Identification of human cell lines for the production of human proteins by endogenous gene activation
11/07/2002US20020164786 Novel telomerase
11/07/2002US20020164785 Nucleotide sequences coding membrane protein for use in the detecting ligand receptors
11/07/2002US20020164784 Novel human 7TM proteins and polynucleotides encoding the same
11/07/2002US20020164783 Nucleotide sequences coding polypeptide for use in the treatment of hereditary respiratory system disorders
11/07/2002US20020164782 Adenovirus vectors for gene therapy
11/07/2002US20020164776 Apparatus for use in transformation of cells
11/07/2002US20020164774 Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions
11/07/2002US20020164772 Multiple drug resistance gene atrD of aspergillus nidulans
11/07/2002US20020164771 Methods for lyophilizing competent cells
11/07/2002US20020164770 DNA transfection system for the generation of infectious influenza virus
11/07/2002US20020164769 Nucleotide sequencces coding polypeptide for use in the treatment of cell proliferative disorders
11/07/2002US20020164768 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of thrombosis and vascular system disorders
11/07/2002US20020164767 DNA encoding the human serine protease C-E
11/07/2002US20020164763 84241, a novel human ring finger family member and uses thereof
11/07/2002US20020164760 Catalytically active recombinant memapsin and methods of use thereof
11/07/2002US20020164758 Enzymatic polypeptide for use in the diagnosis and treatment of allergies, heart and respiratory disorders
11/07/2002US20020164757 Plant proteins
11/07/2002US20020164756 Nucleotide sequences coding polypeptides for use in screening bactericides
11/07/2002US20020164753 Enzymatic polypeptide for use as tools in genetic engineering
11/07/2002US20020164752 47508, a novel human histone deacetylase family member and uses thereof
11/07/2002US20020164749 Enzymatic polypeptide for use in the diagnosis and treatment of tumors
11/07/2002US20020164748 Enzymatic polypeptide for use in the treatment of inflammation, autoimmune and tissue rejection disorders
11/07/2002US20020164747 Gene cluster for ramoplanin biosynthesis
11/07/2002US20020164745 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cell proliferative disorders
11/07/2002US20020164744 Amine oxidase for use in the treatment of alzhemier's, huntington,s and nervous system disorders
11/07/2002US20020164743 Novel cytidine deaminase
11/07/2002US20020164742 DNA encoding methymycin and pikromycin
11/07/2002US20020164738 Cell death inhibitory protein
11/07/2002US20020164737 Novel human kinase and polynucleotides encoding the same
11/07/2002US20020164734 Human pelota homolog
11/07/2002US20020164732 Polypeptide for use in the treatment and prevention of viral infection
11/07/2002US20020164729 Generating polyhydroxyalkanoates; obtain genetically engineered microorganism which expresses preferential enzymes, incubate with butane, hexane, propane, ethane or pentanediol, culture and recover hydroxyalkanoates
11/07/2002US20020164727 Nucleotide sequences coding polypeptide for use as tool in genetic engineering
11/07/2002US20020164722 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide
11/07/2002US20020164721 Design of a polyepitopic construct for the induction of HLA-A2.1 restricted HIV 1 specific CTL responses using HHD mice
11/07/2002US20020164720 Generating 2'-deoxyribonucleoside; obtain microorganism, transform with vector containing ribonucleotide reductase, express vector, incubate with substrate, recover 2'-deoxyribonucleoside
11/07/2002US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002US20020164718 Metal ion affinity tags and methods for usig the same
11/07/2002US20020164716 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
11/07/2002US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer
11/07/2002US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders
11/07/2002US20020164711 Megakaryocyte differentiation factor
11/07/2002US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002US20020164706 Regulating preferential gene expression; obtain cell, transform with expression vector, recover transformed cells, express genes, monitor expression of reporter molecules
11/07/2002US20020164704 Novel human monocyte chemotactic proprotein
11/07/2002US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
11/07/2002US20020164700 Metabolic rate shifts in fermentations expressing recombinant proteins
11/07/2002US20020164698 Identification of Bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction
11/07/2002US20020164697 Nucleotide sequences coding polypeptides for use in treatment of autoimmune disease
11/07/2002US20020164696 Method of producing non-bovine chymosin and use hereof
11/07/2002US20020164695 Generating preferential polypeptides in yeast; obtain yeast, transform with vector containing antitripsin polypeptide, express vector, recover polypeptide
11/07/2002US20020164693 TM4SF receptor polynucleotides, polypeptides, and antibodies
11/07/2002US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies
11/07/2002US20020164691 Human vomeronasal receptor-5
11/07/2002US20020164690 Receptor based antagonists and methods of making and using
11/07/2002US20020164688 Membrane associated protein zupar1
11/07/2002US20020164683 Human sel-10 polypeptides and polynucleotides that encode them
11/07/2002US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002US20020164674 Expression vector for use as diagnostic tool in genetic engineering
11/07/2002US20020164669 Secreted protein HRGDF73
11/07/2002US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
11/07/2002US20020164647 Protein-protein interactions
11/07/2002US20020164646 Nucleotide sequences coding polypeptide for use in the treatment and prevention of Inflammation, tumors, immunological, inflammatory bowel and crohn's disease
11/07/2002US20020164642 Pool of immunoglobulin polypeptides for use in treating and preventing, inflammation, allergies, cancer, bacterial or viral infection, diabetes, arthritis, myasthenia gravis and autoimmune diseases
11/07/2002US20020164641 Detecting modulators of tyrosine kinase activity; obtain expresion vector containg tyrosine kinase polypeptide, express vector, incubate with modulator, monitor adjustment activity or tyrosine kinase
11/07/2002US20020164640 MyD88 adapter-like proteins
11/07/2002US20020164636 High throughput assay for identification of gene expression modifiers
11/07/2002US20020164635 Novel methods of directed evolution
11/07/2002US20020164634 Detecting preferential nucleotide sequences in sample; obtain nucleotide sequences, incubate with probes, hybridize separate, determine which nucleotide sequences hybridized to probe
11/07/2002US20020164632 21529, a novel adenylate cyclase
11/07/2002US20020164629 Analyzing sequence of target polynucleotide; obbtain nucleotide sequences, immobilize to surface of substrate, incubate with label, detect signal, presence of signal indicate preferential sequences
11/07/2002US20020164628 Methods and compositions for amplification of RNA sequences
11/07/2002US20020164627 Novel human transporter proteins and polynucleotides encoding the same
11/07/2002US20020164622 Subtle mitochondrial mutations as tumor markers
11/07/2002US20020164621 Expression cloning using a tagged cDNA library
11/07/2002US20020164618 Enzymes having high temperature polymerase activity and methods of use thereof
11/07/2002US20020164617 Affinity selection-based screening of hydrophobic proteins
11/07/2002US20020164614 Hybridizind probes and target nucleotide sequences; obtain test sample of nucleotide sequences, incubate with probe, denature, hybridize, detect hybridization
11/07/2002US20020164612 Testing endosymbiont cellular organelles and compounds identifiable therewith
11/07/2002US20020164611 Oligonucleotide identifiers
11/07/2002US20020164608 Evaluating humans for vision defects; obtain nusleotide sequences sample, incubate with probe, detect hybridization of probe to preferential allele, hybridization indicates sensitivinty to vision defect